Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion type Assertion NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_head.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion description "[When paired with emerging data on the relative safety and efficacy of breast cancer genetic testing for high risk women and the advent of direct-to-consumer marketing of BRCA1/2 cancer genetic tests, professional societies may need to explore best practices to counsel high risk families and their PCPs about the potential risks and benefits of pediatric BRCA1/2 testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_provenance.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion evidence source_evidence_literature NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_provenance.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion SIO_000772 19390990 NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_provenance.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion wasDerivedFrom befree-2016 NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_provenance.
- NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_assertion wasGeneratedBy ECO_0000203 NP734472.RAebbcC22Tpojs-p4KWe6kCeG-fTOXpwhvZlLYIKy4aLI130_provenance.